Join to View Full Profile
500 University DrHershey, PA 17033
Phone+1 717-531-8024
Fax+1 717-531-0882
Dr. Rupard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Erik Rupard is an oncologist in West Reading, PA and is affiliated with Reading Hospital. He received his medical degree from Uniformed Services University of the Health Sciences F. Edward Hebert School of Medicine and has been in practice 19 years. He is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2002 - 2005- National Capital ConsortiumResidency, Internal Medicine, 1998 - 2001
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1998
Certifications & Licensure
AZ State Medical License 2023 - 2028
CA State Medical License 2025 - 2028
MT State Medical License 2023 - 2027
NV State Medical License 2023 - 2027
AK State Medical License 2024 - 2026
ID State Medical License 2023 - 2026
PA State Medical License 2012 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2013-2017
Clinical Trials
- Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer Start of enrollment: 2013 Apr 25
Publications & Presentations
PubMed
- 31 citationsTreatment of Unicentric Castleman Disease With Neoadjuvant RituximabBradley Bandera, Craig Ainsworth, James F Shikle, Erik Rupard, Michael C. Roach
Chest. 2010-11-01 - 4 citationsBasal cell carcinoma with hepatic metastases.Jessica F Gold, Daniel J Boudreaux, Erik J Rupard
American Journal of Clinical Oncology. 2007-12-01 - A 38-year-old staff sergeant with fevers, chest pain, and shortness of breath.Allen J. Taylor, Erik J. Rupard
Military Medicine. 2001-10-01
Press Mentions
New Intermountain Health TeleOncology Partnership Brings Life-Saving Cancer Care Closer to Home to Interior AlaskaAugust 19th, 2025- Reading Hospital Foundation Announces Fundraising Campaign for Mobile Mammography UnitOctober 8th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
